Caffeine does not increase the risk of atrial fibrillation: a systematic review and meta-analysis of observational

Daniel Caldeira1, Cristina Martins, Luís Brandão Alves

  • 1Laboratory of Clinical Pharmacology and Therapeutics, Faculty of Medicine, University of Lisbon, Lisboa, Portugal. dgcaldeira@hotmail.com

Insights

Caffeine consumption does not increase the risk of atrial fibrillation (AF). Low-dose caffeine intake may even offer a protective effect against AF, according to a meta-analysis of observational studies.

Area of Science:

  • Cardiology
  • Epidemiology
  • Pharmacology

Background:

  • Atrial fibrillation (AF) is a common heart arrhythmia with established risk factors.
  • Previous research on caffeine's association with AF risk has yielded inconsistent results.

Purpose of the Study:

  • To systematically evaluate the relationship between chronic caffeine exposure and the risk of developing atrial fibrillation.
  • To synthesize existing observational data to clarify caffeine's role in AF etiology.

Main Methods:

  • A systematic review and meta-analysis of observational studies were conducted.
  • Searches of major databases (PubMed, CENTRAL, ISI Web of Knowledge, LILACS) up to December 2012 identified relevant studies.
  • Data from seven observational studies, including 115,993 participants, were analyzed using random-effects models.

Main Results:

  • Overall caffeine exposure was not associated with an increased risk of AF (OR 0.92, 95% CI 0.82 to 1.04).
  • High-quality studies indicated a potential 13% reduction in AF risk with caffeine consumption (OR 0.87, 95% CI 0.80 to 0.94).
  • Low-dose caffeine intake demonstrated a significant protective effect (OR 0.85, 95% CI 0.78 to 0.92) with no heterogeneity.

Conclusions:

  • Caffeine exposure is not linked to a higher risk of atrial fibrillation.
  • Low-dose caffeine consumption may exert a protective influence on AF development.
  • Further research into dose-dependent effects of caffeine on cardiovascular health is warranted.
Abstract

Related Concept Videos

Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers01:24

Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers

Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which indirectly block calcium...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response01:15

Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response

Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
Stimulants01:29

Stimulants

Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...